HERITAGE INVESTORS MANAGEMENT CORP
Position in ELAN — Elanco Animal Health Inc
CIK 937589
BETHESDA, MD
Position in ELAN
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$3,035,065
+$103,869 QoQ
Shares Held
126,831
-2.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HERITAGE INVESTORS MANAGEMENT CORP holds $32,059,665 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
209,297 | $24,740,998 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
126,831 | $3,035,065 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
98,339 | $1,821,238 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
50,960 | $1,534,915 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
7,040 | $927,449 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,035,065 | 126,831 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,931,196 | 129,527 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,651,813 | 131,669 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,120,137 | 148,469 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,622,754 | 154,548 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,942,322 | 160,390 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,360,168 | 160,665 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,332,970 | 161,675 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,803,074 | 172,179 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,593,747 | 174,077 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,984,939 | 176,596 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,846,341 | 183,533 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,784,825 | 189,875 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $2,220,374 | 181,700 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,224,219 | 179,228 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $3,480,241 | 177,292 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,662,491 | 178,708 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,871,285 | 171,645 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $5,433,099 | 170,370 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,908,296 | 170,317 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $5,186,468 | 176,111 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,511,245 | 179,695 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $5,157,721 | 184,666 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,020,352 | 187,429 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,135,410 | 184,699 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||